2013, Number 2
<< Back Next >>
Arch Med Urg Mex 2013; 5 (2)
Guidelines for the management of acute asthma
Bermeo LA, Velasco DV
Language: Spanish
References: 45
Page: 60-69
PDF size: 201.59 Kb.
ABSTRACT
Asthma is a major health problem of global importance. Unfortunately, the diagnosis and management of asthma are heterogeneous and often inadequate, resulting in decreased quality of life and increased economic costs, suffering, and death. The guide is intended to give the intended diagnostic and therapeutic tools to deal with quality to this.
REFERENCES
Consenso Mexicano de Asma; Neumología y Cirugía de Tórax: 2005; 64 (S1): S7-S44.
Cano AG, González MJ, Herrero LA, Martín MJ. Asma y crisis asmática. Principios de urgencias, Emergencias y cuidados críticos 2009. www.uninet.edu/tratado/c0207i.htlm
Busey JF, Fenger EP, Hepper NG. Management of status asthmaticus. A statement by the Committee on Therapy. Am Rev Respir Dis 1968; 97: 735-736.
Guía Española para el Manejo del Asma. Gema, 2009.
McFadden ER Jr. Acute severe asthma. Am J Respir Crit Care Med 2003; 168: 740-759.
The Global Burden of Asthma Report. GINA 2007. www.ginasthma.org
Braman, SS. Asthma in the elderly. Clin Geriatr Med 2003; 19: 57-75.
Tschopp JM, Sistek D, Schindler Ch, Leuenberger Ph, Perruchoud AP, Wüthrich B et al. Current allergic asthma and rhinitis: diagnostic efficiency of three commonly used atopic markers (IgE, skin prick tests, and Phadiatop). Results from 8,329 randomized adults from the SAPALDIA study. Allergy 1998; 53: 608-613.
Beach J, Russell K, Blitz S, Hooton N, Spooner C, Lemiere C et al. A systematic review of the diagnosis of occupational asthma. Chest 2007; 131: 569-578.
GINA 2002. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention: NHLBI/WHO Report. Bethesda: National Institutes of Health, National Heart, Lung, and Blood Institute, 2002. Publication 02-3659.
NAEPP 2002. Nacional Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma: Expert Panel Report 2. Bethesda: National Institutes of Health, National Heart, Lung, and Blood Institute, 2002. Publication 97-4051.
Plaza V, Álvarez FJ, Casan P, Cobos N, López VA et al. En calidad de Comité Ejecutivo de la GEMA y en representación del grupo de redactores. Guía Española para el Manejo del Asma (GEMA 2003). Arch Bronconeumol 2003; 39(Suppl 5): 1-42.
Reisner C, Kotch A, Dworkin G. Continuous versus frequent intermittent nebulization of albuterol in acute asthma: a randomized, prospective study. Ann Allergy Asthma Immunol 1995; 75(1): 41-47.
Cates CJ, Crilly JA, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database of Sys Rev 2006; 2: CD000052.
Manser R, Reid D, Abramson M. Corticosteroids for acute severe asthma in hospitalised patients. Cochrane Database Syst Rev 2000: 2.
Hasegawa T, Ishihara K, Takakura S, Fujii H, Nishimura T, Okazaki M et al. Duration of systemic corticosteroids in the treatment of asthma exacerbation: a randomized study. Intern Med 2000; 39(10): 794-797.
Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Corticosteroids for preventing relapse following acute exacerbation of asthma (Cochrane Review). London: John Wiley & Sons Ltd. The Cochrane Library. 2001; 3.
Rowe BH, Spooner CH, Ducharme FM, Bota GW. Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database Sys Rev 2007; 3: CD000195.
Osman LM, Calder C, Godden DJ, Friend JA, McKenzie L, Legge JS et al. A randomized trial of self-management planning for adult patients admitted to hospital with acute asthma. Thorax 2002; 57: 869-74.
Rodrigo GJ, Rodríguez-Verde M, Peregalli V, Rodrigo C. Effects of short term 28% and 100% oxygen in PaCO2 and peak expiratory flow rate in acute asthma: a randomized trial. Chest 2003; 124: 1312-1317.
Rodrigo C, Rodrigo G. Therapeutic response patterns to high and cumulative doses of salbutamol in acute severe asthma. Chest 1998; 113: 593-598.
Camargo CA Jr, Spooner CH, Rowe BH. Continuous versus intermittent beta-agonists for acute asthma. Cochrane Database of Syst Rev 2003; 4: CD001115.
Travers A, Jones AP, Kelly K, Barker SJ, Camargo CA, Rowe BH. Intravenous beta2-agonists for acute asthma in the emergency department. Cochrane Database of Sys Rev 2001; 2: CD002988.
Rubinfeld AR, Scicchitano R, Hunt A, Thompson PJ, van Nooten A, Selroos O. Formoterol Turbuhaler as reliever medication in patients with acute asthma. Eur Respir J 2006; 27: 735-741.
Rodrigo GJ, Castro-Rodriguez JA. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Thorax 2005; 60: 740-746.
Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Sys Rev 2001; 1: CD002178.
Rodrigo GJ. Rapid effects of inhaled corticosteroids in acute asthma: an evidence-based evaluation. Chest 2006; 130: 1301-1311.
Rodrigo GJ, Nannini LJ. Is there a place for nebulized magnesium sulfate in the treatment of acute asthma? A systematic review. Curr Ther 2006; 1: 181-185.
Rowe BH, Bretzlaff JA, Bourdon C, Bota GW, Camargo CA Jr. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. Cochrane Database Sys Rev 2000; 2: CD001490.
Parameswaran K, Belda J, Rowe BH. Addition of intravenous aminophylline to beta2-agonists in adults with acute asthma. Cochrane Database Sys Rev 2000; 4: CD002742.
Rodrigo G, Pollack C, Rodrigo C, Rowe BH. Heliox for nonintubated acute asthma patients. Cochrane Database Sys Rev 2006; 4: CD002884.
Tuxen DV. Permissive hypercapnic ventilation. Am J Respir Crit Care Med 1994; 150: 870-874.
Strauss L, Hejal R, Galan G, Dixon L, McFadden ER Jr. Observations of the effects of aerosolized albuterol in acute asthma. Am J Respir Crit Care Med 1997; 155: 454-458.
Grunfeld A, Fitzgerald JM. Discharge considerations in acute asthma. Can Respir J 1996; 3: 322-324.
Udwadia ZF, Harrison BD. An attempt to determine the optimal duration of hospital stay following a severe attack of asthma. J R Coll Physicians Lond 1990; 24: 112-114.
Pearson MG, Ryland I, Harrison BD. National audit of acute severe asthma in adults admitted to hospital. Standards of Care Committee, British Thoracic Society. Qual Health Care 1995; 4: 24-30.
Rodrigo GJ, Rodrigo C, Nannini LJ. Asma fatal o casi fatal: ¿entidad clínica o manejo inadecuado? Arch bronconeumol 2004; 40: 24-33.
Hall JB, Wood L. Status asthmaticus. In: Hall JB, Schmidt GA, Wood L, eds: Principles of Critical Care. New York: McGraw-Hill, 1992; 1670-1679.
Darioli R, Perret C. Mechanical controlled hypoventilation in status asthmaticus. Am Rev Respir Dis 1984; 129: 385-387.
Tuxen DV. Permissive hypercapnia. In: Tobin MJ. Principles and practice of mechanical ventilation. New York: McGraw-Hill, New York, 1994; 371-392.
Stewart TE, Slutsky AS. Occult, occult auto-PEEP in status asthmaticus. Crit Care Med 1996; 24: 379-380.
Perret C, Feihl F. Respiratory failure in asthma: Management of the mechanically ventilated patient. In: Vincent JL, ed: 1992 Yearbook of Intensive Care and Emergency Medicine. Berlín, Springer-Verlag, 1992; 364-371.
Stewart TE, Slutsky AS. Occult, occult auto-PEEP in status asthmaticus. Crit Care Med 1996; 24: 379-380.
Tuxen DV. Detrimental effects of positive end-expiratory pressure during controlled mechanical ventilation of patients with severe airflow obstruction. Am Rev Respir Dis 1989; 140: 5-9.
Limthongkul S, Udompanich V, Wongthim S et al. Status asthmaticus: an analysis of 560 episodes and comparison between mechanical and non-mechanical ventilation groups. J Med Assoc Thai 1990; 73: 495-501.